Global Ocular Inflammation Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1082

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
In 2018, the global Ocular Inflammation Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ocular Inflammation Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ocular Inflammation Treatment development in United States, Europe and China.

The key players covered in this study
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.
pSivida Corporation

Market segment by Type, the product can be split into
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal

Market segment by Application, split into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ocular Inflammation Treatment status, future forecast, growth opportunity, key market and key players.
To present the Ocular Inflammation Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ocular Inflammation Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunosuppressant
1.4.3 Monoclonal Antibodies
1.4.4 Corticosteroids
1.4.5 Cycloplegic Agents
1.4.6 Antibiotics
1.4.7 Analgesics
1.4.8 Antivirals
1.4.9 Antifungal
1.5 Market by Application
1.5.1 Global Ocular Inflammation Treatment Market Share by Application (2014-2025)
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ocular Inflammation Treatment Market Size
2.2 Ocular Inflammation Treatment Growth Trends by Regions
2.2.1 Ocular Inflammation Treatment Market Size by Regions (2014-2025)
2.2.2 Ocular Inflammation Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ocular Inflammation Treatment Market Size by Manufacturers
3.1.1 Global Ocular Inflammation Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Ocular Inflammation Treatment Key Players Head office and Area Served
3.3 Key Players Ocular Inflammation Treatment Product/Solution/Service
3.4 Date of Enter into Ocular Inflammation Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ocular Inflammation Treatment Market Size by Type (2014-2019)
4.2 Global Ocular Inflammation Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Ocular Inflammation Treatment Market Size (2014-2019)
5.2 Ocular Inflammation Treatment Key Players in United States
5.3 United States Ocular Inflammation Treatment Market Size by Type
5.4 United States Ocular Inflammation Treatment Market Size by Application

6 Europe
6.1 Europe Ocular Inflammation Treatment Market Size (2014-2019)
6.2 Ocular Inflammation Treatment Key Players in Europe
6.3 Europe Ocular Inflammation Treatment Market Size by Type
6.4 Europe Ocular Inflammation Treatment Market Size by Application

7 China
7.1 China Ocular Inflammation Treatment Market Size (2014-2019)
7.2 Ocular Inflammation Treatment Key Players in China
7.3 China Ocular Inflammation Treatment Market Size by Type
7.4 China Ocular Inflammation Treatment Market Size by Application

8 Japan
8.1 Japan Ocular Inflammation Treatment Market Size (2014-2019)
8.2 Ocular Inflammation Treatment Key Players in Japan
8.3 Japan Ocular Inflammation Treatment Market Size by Type
8.4 Japan Ocular Inflammation Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ocular Inflammation Treatment Market Size (2014-2019)
9.2 Ocular Inflammation Treatment Key Players in Southeast Asia
9.3 Southeast Asia Ocular Inflammation Treatment Market Size by Type
9.4 Southeast Asia Ocular Inflammation Treatment Market Size by Application

10 India
10.1 India Ocular Inflammation Treatment Market Size (2014-2019)
10.2 Ocular Inflammation Treatment Key Players in India
10.3 India Ocular Inflammation Treatment Market Size by Type
10.4 India Ocular Inflammation Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Ocular Inflammation Treatment Market Size (2014-2019)
11.2 Ocular Inflammation Treatment Key Players in Central & South America
11.3 Central & South America Ocular Inflammation Treatment Market Size by Type
11.4 Central & South America Ocular Inflammation Treatment Market Size by Application

12 International Players Profiles
12.1 Allergan Plc.
12.1.1 Allergan Plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ocular Inflammation Treatment Introduction
12.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.1.5 Allergan Plc. Recent Development
12.2 Cipla Ltd.
12.2.1 Cipla Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ocular Inflammation Treatment Introduction
12.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.2.5 Cipla Ltd. Recent Development
12.3 Pfizer, Inc.
12.3.1 Pfizer, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ocular Inflammation Treatment Introduction
12.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.3.5 Pfizer, Inc. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ocular Inflammation Treatment Introduction
12.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Valeant Pharmaceuticals International, Inc.
12.5.1 Valeant Pharmaceuticals International, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ocular Inflammation Treatment Introduction
12.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
12.6 Alimera Sciences, Inc.
12.6.1 Alimera Sciences, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ocular Inflammation Treatment Introduction
12.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.6.5 Alimera Sciences, Inc. Recent Development
12.7 Akorn, Inc.
12.7.1 Akorn, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ocular Inflammation Treatment Introduction
12.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.7.5 Akorn, Inc. Recent Development
12.8 Abbvie, Inc.
12.8.1 Abbvie, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ocular Inflammation Treatment Introduction
12.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.8.5 Abbvie, Inc. Recent Development
12.9 Eyegate Pharmaceuticals, Inc.
12.9.1 Eyegate Pharmaceuticals, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ocular Inflammation Treatment Introduction
12.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
12.10 pSivida Corporation
12.10.1 pSivida Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Ocular Inflammation Treatment Introduction
12.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2014-2019)
12.10.5 pSivida Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details